Forever young: the business of longevity drugs

Pharmaceutical companies are increasingly targeting longevity, viewing it as a massive commercial opportunity similar to the success of GLP-1 drugs. While AI-driven biotech firms lead early research, the lack of FDA recognition for aging as a disease forces developers to target specific age-related conditions first. Meanwhile, public claims regarding high sexual offense rates among Afghan immigrants in Britain lack statistical rigor. When adjusting for demographic skews and population changes, the data shows that conviction rates are far lower than sensationalist reports suggest, with the vast majority of such crimes committed by British citizens. Beyond these serious topics, the resurgence of miniature crafting offers a whimsical form of escapism. This growing hobby provides a hands-on, analogue outlet for creative expression, allowing enthusiasts to build intricate, controlled worlds that offer stability in uncertain times.